{
  "results": [
    {
      "statement": "Vitamin D deficiency is common in patients with inflammatory bowel disease",
      "evaluation": "yes",
      "reason": "Multiple studies confirm high prevalence of vitamin D deficiency in IBD patients, with rates ranging from 35-70% depending on the population studied.",
      "evidence_list": [
        {
          "citation": "Vitamin D deficiency is highly prevalent in patients with inflammatory bowel disease (IBD), with studies showing 35-70% of IBD patients have insufficient vitamin D levels. This deficiency may contribute to disease activity and bone health complications.",
          "pmid": "PMID:23456789",
          "relevance_score": 4.8,
          "stance": "supports"
        },
        {
          "citation": "Cross-sectional analysis of 965 IBD patients revealed 58% had vitamin D insufficiency (<30 ng/mL), with higher rates in Crohn's disease (62%) compared to ulcerative colitis (54%).",
          "pmid": "PMID:23456790",
          "doi": "DOI:10.1016/j.example.2023.01.001",
          "relevance_score": 4.5,
          "stance": "supports"
        },
        {
          "citation": "Vitamin D supplementation in IBD patients improved serum 25(OH)D levels but showed mixed results on disease activity outcomes in randomized controlled trials.",
          "pmid": "PMID:23456791",
          "relevance_score": 3.9,
          "stance": "neutral"
        }
      ],
      "confidence": "high",
      "metadata": {
        "documents_reviewed": 12,
        "supporting_citations": 2,
        "contradicting_citations": 0,
        "neutral_citations": 1,
        "timestamp": "2025-11-11T10:30:00Z"
      },
      "expected_answer": "yes",
      "matches_expected": true
    },
    {
      "statement": "All cases of childhood ulcerative colitis require colectomy",
      "evaluation": "no",
      "reason": "Evidence clearly shows that colectomy is NOT required for all cases. While some severe or refractory cases may need surgery, many children achieve remission with medical therapy.",
      "evidence_list": [
        {
          "citation": "Pediatric ulcerative colitis management has evolved with biologic therapies, allowing many children to avoid colectomy. Current data shows approximately 10-20% of pediatric UC patients require colectomy within 5 years of diagnosis.",
          "pmid": "PMID:34567890",
          "relevance_score": 4.9,
          "stance": "contradicts"
        },
        {
          "citation": "A multicenter study of 340 children with UC found that 82% achieved clinical remission with medical therapy (5-ASA, immunomodulators, or biologics) and did not require surgical intervention during 3-year follow-up.",
          "pmid": "PMID:34567891",
          "doi": "DOI:10.1002/example.2023.02.002",
          "relevance_score": 4.7,
          "stance": "contradicts"
        },
        {
          "citation": "Indications for colectomy in pediatric UC include medically refractory disease, toxic megacolon, perforation, dysplasia, or cancer. These severe complications affect a minority of patients.",
          "pmid": "PMID:34567892",
          "relevance_score": 4.2,
          "stance": "contradicts"
        }
      ],
      "confidence": "high",
      "metadata": {
        "documents_reviewed": 15,
        "supporting_citations": 0,
        "contradicting_citations": 3,
        "neutral_citations": 0,
        "timestamp": "2025-11-11T10:35:00Z"
      },
      "expected_answer": "no",
      "matches_expected": true
    },
    {
      "statement": "Probiotics are effective for all forms of inflammatory bowel disease",
      "evaluation": "maybe",
      "reason": "Evidence is mixed. Some probiotic strains show benefit for specific conditions (e.g., VSL#3 for pouchitis), but efficacy varies by IBD type, strain used, and individual patient factors. Not effective for all forms.",
      "evidence_list": [
        {
          "citation": "VSL#3 probiotic mixture demonstrated efficacy in maintaining remission of chronic pouchitis in randomized controlled trials, with 85% of patients maintaining remission vs. 6% with placebo.",
          "pmid": "PMID:45678901",
          "relevance_score": 4.6,
          "stance": "supports"
        },
        {
          "citation": "Meta-analysis of probiotic trials in Crohn's disease showed no significant benefit for inducing or maintaining remission, with most studies showing neutral or negative results.",
          "pmid": "PMID:45678902",
          "doi": "DOI:10.1053/example.2023.03.003",
          "relevance_score": 4.3,
          "stance": "contradicts"
        },
        {
          "citation": "Probiotic efficacy in ulcerative colitis appears strain-specific and modest. E. coli Nissle 1917 showed equivalence to mesalamine for maintaining remission in some trials, but other strains showed minimal benefit.",
          "pmid": "PMID:45678903",
          "relevance_score": 4.1,
          "stance": "neutral"
        },
        {
          "citation": "Current clinical guidelines recommend probiotics only for specific indications (pouchitis prevention/treatment) and note insufficient evidence to recommend routine use across all IBD subtypes.",
          "pmid": "PMID:45678904",
          "relevance_score": 4.4,
          "stance": "contradicts"
        }
      ],
      "confidence": "medium",
      "metadata": {
        "documents_reviewed": 18,
        "supporting_citations": 1,
        "contradicting_citations": 2,
        "neutral_citations": 1,
        "timestamp": "2025-11-11T10:40:00Z"
      },
      "expected_answer": "maybe",
      "matches_expected": true
    }
  ],
  "summary": {
    "total_statements": 3,
    "evaluations": {
      "yes": 1,
      "no": 1,
      "maybe": 1,
      "error": 0
    },
    "confidences": {
      "high": 2,
      "medium": 1,
      "low": 0
    },
    "validation": {
      "matches": 3,
      "mismatches": 0,
      "accuracy": 1.0
    }
  }
}
